April 6, 2016 / 8:07 PM / a year ago

BRIEF-Cipher Pharmaceuticals announces approvals of SD Cream and AD Cream

1 Min Read

April 6 (Reuters) - Cipher Pharmaceuticals Inc

* Cipher Pharmaceuticals announces approvals of astion acquired barrier creams by Health Canada and the Medicines Evaluation Board

* Says in addition European approval of helioclin pruritus SD cream (also known as pruridexin) was achieved

* In Canada , Cipher plans to market products through its internal sales team

* Says company expects to out-license helioclin pruritus sd cream and helioclin dermatitis SD cream in Europe Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1-646-223-8780)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below